Eden Health GLP-1 vs MEDVi: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher & Publisher
MEDVi beats Eden Health GLP-1 overall, scoring 7.7/10 vs 6.9/10. MEDVi is more affordable at $179/mo vs $249/mo. Choose Eden Health GLP-1 for people with diabetes, heart conditions, or other risk factor. Choose MEDVi for users who want a low entry price with oral and injectable co.
A side-by-side look at Eden Health GLP-1 and MEDVi to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Eden Health GLP-1
#44 of 53Premium online weight-loss program from Eden Health (San Francisco, founded 2021). Different from competitors in one specific way: every patient is paired with a board-certified obesity medicine doctor (a doctor with specialized training in weight and metabolism), not a general practitioner or nurse. Quarterly blood panels (metabolic, lipid, A1C) are included in the monthly cost. Eden prescribes both compounded GLP-1s (custom-made versions, not the FDA-approved brand) and brand-name Wegovy, Zepbound, Ozempic, and Mounjaro.
Visit Eden Health GLP-1MEDVi
#18 of 53MEDVi is a compounded GLP-1 telehealth platform offering both oral tablets and injectable semaglutide and tirzepatide, with micro-dosing options for side-effect-sensitive patients. $179/mo entry pricing, free shipping, and a streamlined intake, one of the broader compounded mixes among independent telehealth providers in 2026.
Visit MEDVi| Feature | Eden Health GLP-1 | MEDVi |
|---|---|---|
| Why each one | The only telehealth GLP-1 platform staffed by board-certified obesity medicine doctors (specialists in weight and metabolism), with quarterly lab panels included, the closest thing to in-person bariatric care delivered by mail. | The only compounded GLP-1 platform offering a structured oral-to-injectable transition pathway with micro-dosing options for side-effect-sensitive patients. |
| Our Score | 6.9/10 | 7.7/10 |
| Starting Price | $249/mo | $179/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
| Best For | People with diabetes, heart conditions, or other risk factors who want a doctor (not a nurse) overseeing their GLP-1, with blood panels included. | Users who want a low entry price with oral and injectable compounded options |
| Watch out for | $249/mo ongoing (month-to-month) is on the high end. Henry Meds is $199/mo for similar compounded care without labs; MEDVi is $179/mo. | No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only) |
| Ranking | #44 | #18 |
| Get started | Visit Eden Health GLP-1 | Visit MEDVi |
Pros & Cons Compared
Eden Health GLP-1
Pros
- +4.5 stars across 3,777 verified Trustpilot reviews, 77% give 5 stars. Replies to 99% of negative reviews. The strongest customer-experience signal of any provider in our table.
- +Doctors are board-certified obesity medicine specialists, not general practitioners. Specialized training in weight and metabolism.
- +Quarterly blood panels (metabolic, lipid, A1C) are included in the monthly price. Most competitors don't include labs.
- +Mandatory check-in with the doctor before each dose increase. Won't rush you up the ladder.
- +Full medication choice: compounded semaglutide/tirzepatide AND brand-name Wegovy, Zepbound, Ozempic, Mounjaro.
Cons
- −$249/mo ongoing (month-to-month) is on the high end. Henry Meds is $199/mo for similar compounded care without labs; MEDVi is $179/mo.
- −Cash-pay only, no insurance billing.
- −Cancellation friction is the main 1-star Trustpilot complaint (13% of reviews). Some users report being billed or shipped after they canceled.
- −Their website is not always user-friendly, multiple Trustpilot users mention they had to contact support to make payment or account changes.
- −Pharmacy partner not named specifically, 'state-licensed compounding pharmacies' in their marketing, but no individual facility named.
MEDVi
Pros
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available, can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
Cons
- −No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag
Our Verdict
MEDVi edges out Eden Health GLP-1 with a score of 7.7/10 vs 6.9/10. If budget is your priority, MEDVi is $179/mo for the first month, then $299/mo compared to Eden Health GLP-1 at $249/mo for the first month, rises after. Choose Eden Health GLP-1 if you want: people with diabetes, heart conditions, or other risk factors who want a doctor (not a nurse) overseeing their glp-1, with blood panels included.. Choose MEDVi if you want: users who want a low entry price with oral and injectable compounded options.
Cheapest in our index
Embody
$69/mo flat rate · 7.3/10 · Compounded
Both Eden Health GLP-1 and MEDVi start above the cheapest program we track. Across all 53 providers in our index, that floor is Embody at a flat $69/mo, the same rate at every dose, price checked July 31, 2026. It scores 7.3/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.
Read Full Reviews
Related comparisons
Other matchups readers comparing Eden Health GLP-1 or MEDVi tend to look at next.
- Eden Health GLP-1 vs Zealthy$286/mo
- Eden Health GLP-1 vs Found$129/mo
- Eden Health GLP-1 vs Enhance MD$212/mo
- MEDVi vs Shed$199/mo
- MEDVi vs AgelessRx$199/mo
- MEDVi vs Hers$199/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: MEDVi · 7.7/10